Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.77 USD | +3.19% | +4.00% | -23.36% |
May. 31 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
May. 31 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.36% | 5.65B | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+39.53% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Transcript : Ionis Pharmaceuticals, Inc. Presents at TD Cowen’s 2nd Annual RNA Therapeutics Summit, Jul-10-2023 10